214 related articles for article (PubMed ID: 27431011)
1. Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.
Ramakrishnan R; Balu-Iyer SV
J Pharm Sci; 2016 Oct; 105(10):3039-3045. PubMed ID: 27431011
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.
Glassman FY; Balu-Iyer SV
Int J Pharm; 2018 Sep; 548(1):642-648. PubMed ID: 29981412
[TBL] [Abstract][Full Text] [Related]
3. Exposure of FVIII in the Presence of Phosphatidyl Serine Reduces Generation of Memory B-Cells and Induces Regulatory T-Cell-Mediated Hyporesponsiveness in Hemophilia A Mice.
Ramakrishnan R; Davidowitz A; Balu-Iyer SV
J Pharm Sci; 2015 Aug; 104(8):2451-6. PubMed ID: 26038127
[TBL] [Abstract][Full Text] [Related]
4. Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice.
Gaitonde P; Ramakrishnan R; Chin J; Kelleher RJ; Bankert RB; Balu-Iyer SV
J Biol Chem; 2013 Jun; 288(24):17051-6. PubMed ID: 23649621
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function.
Gaitonde P; Peng A; Straubinger RM; Bankert RB; Balu-Iyer SV
Clin Immunol; 2011 Feb; 138(2):135-45. PubMed ID: 21094627
[TBL] [Abstract][Full Text] [Related]
6. O-phospho-l-serine mediates hyporesponsiveness toward FVIII in hemophilia A-murine model by inducing tolerogenic properties in dendritic cells.
Fathallah AM; Ramakrishnan R; Balu-Iyer SV
J Pharm Sci; 2014 Nov; 103(11):3457-3463. PubMed ID: 25266204
[TBL] [Abstract][Full Text] [Related]
7. Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.
Rossi G; Sarkar J; Scandella D
Blood; 2001 May; 97(9):2750-7. PubMed ID: 11313267
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.
Ramani K; Miclea RD; Purohit VS; Mager DE; Straubinger RM; Balu-Iyer SV
J Pharm Sci; 2008 Apr; 97(4):1386-98. PubMed ID: 17705286
[TBL] [Abstract][Full Text] [Related]
9. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
10. Long-term tolerance to factor VIII is achieved by administration of interleukin-2/interleukin-2 monoclonal antibody complexes and low dosages of factor VIII.
Liu CL; Ye P; Lin J; Djukovic D; Miao CH
J Thromb Haemost; 2014 Jun; 12(6):921-31. PubMed ID: 24684505
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of lipidic cochleate containing recombinant factor VIII.
Miclea RD; Varma PR; Peng A; Balu-Iyer SV
Biochim Biophys Acta; 2007 Nov; 1768(11):2890-8. PubMed ID: 17936245
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.
Glassman FY; Schneider JL; Ramakrishnan R; Dingman RK; Ramanathan M; Bankert RB; Balu-Iyer SV
J Pharm Sci; 2018 Aug; 107(8):2048-2054. PubMed ID: 29649469
[TBL] [Abstract][Full Text] [Related]
13. Induction of tolerance to factor VIII by transient co-administration with rapamycin.
Moghimi B; Sack BK; Nayak S; Markusic DM; Mah CS; Herzog RW
J Thromb Haemost; 2011 Aug; 9(8):1524-33. PubMed ID: 21585650
[TBL] [Abstract][Full Text] [Related]
14. Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A.
Madoiwa S; Yamauchi T; Hakamata Y; Kobayashi E; Arai M; Sugo T; Mimuro J; Sakata Y
J Thromb Haemost; 2004 May; 2(5):754-62. PubMed ID: 15099282
[TBL] [Abstract][Full Text] [Related]
15. Animal models to explore mechanisms of tolerance induction to FVIII: SCID mice and SCID-FVIII-KO mice.
Gilles JG; Vanzieleghem B; Saint-Remy JM
Haematologica; 2000 Oct; 85(10 Suppl):103-6; discussion 106-7. PubMed ID: 11187860
[No Abstract] [Full Text] [Related]
16. Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
Shetty KA; Kosloski MP; Mager DE; Balu-Iyer SV
Biopharm Drug Dispos; 2016 Oct; 37(7):409-420. PubMed ID: 27418232
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant facilitates tolerance induction to factor VIII in hemophilic mice through a Foxp3-independent mechanism that relies on IL-10.
Oliveira VG; Agua-Doce A; Curotto de Lafaille MA; Lafaille JJ; Graca L
Blood; 2013 May; 121(19):3936-45, S1. PubMed ID: 23532736
[TBL] [Abstract][Full Text] [Related]
18. Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation.
Zhang AH; Rossi RJ; Yoon J; Wang H; Scott DW
Cell Immunol; 2016 Mar; 301():74-81. PubMed ID: 26687613
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates.
Kosloski MP; Peng A; Varma PR; Fathallah AM; Miclea RD; Mager DE; Balu-iyer SV
Drug Deliv; 2011 May; 18(4):246-54. PubMed ID: 21114461
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
